When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 15 Mar 2025
Last updated: 10 May 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • spasms
  • head nodding
  • neurodevelopmental delay or regression

Other diagnostic factors

  • onset age 3-12 months
  • perinatal complication
  • abnormal eye movements
  • microcephaly
  • ash-leaf macules
  • motor system abnormalities

Risk factors

  • brain malformation
  • neurocutaneous abnormalities
  • antenatal or perinatal vascular event
  • intrauterine or perinatal infections
  • inherited metabolic disorder
  • genetic disorders
  • family history
  • neonatal sinovenous thrombosis
  • postnatal brain injury
  • brain tumours

Diagnostic investigations

1st investigations to order

  • sleep electroencephalogram (EEG)
  • full blood count
  • urea and electrolytes
  • plasma glucose
  • serum calcium
  • serum magnesium
  • liver function tests
  • ammonia
  • blood gas
  • plasma lactate/pyruvate
  • plasma amino acids
  • urine organic acids
  • acylcarnitines (blood spot)
  • biotinidase
  • urine alpha-amino adipic semialdehyde dehydrogenase (AASA)
  • urine and plasma creatine and guanidinoacetate
  • next-generation sequencing: gene panel/whole-exome sequencing/whole-genome sequencing
  • microarray comparative genome hybridisation (CGH)
  • brain MRI

Investigations to consider

  • cerebrospinal fluid (CSF) examination
  • thyroid function tests (free thyroxine [FT4], thyroid-stimulating hormone [TSH])
  • plasma transferrin glycoforms
  • very long-chain fatty acids
  • serum copper, ceruloplasmin
  • urine sulfocysteine
  • CT brain
  • cytomegalovirus (CMV) culture, polymerase chain reaction (PCR), or serology
  • toxoplasmosis serology
  • echocardiogram
  • renal ultrasound
  • ophthalmology examination

Treatment algorithm

ONGOING

Contributors

Authors

Robert Robinson, MA, MBBS, FRCP, PhD

Consultant Paediatric Neurologist

Great Ormond Street Hospital

London

UK

Disclosures

RR declares that he has no competing interests.

Sarah Buts, MD

Clinical Fellow in Paediatric Neurology

Great Ormond Street Hospital

London

UK

Disclosures

SB declares that she has no competing interests.

Acknowledgements

Dr Robert Robinson and Dr Sarah Buts would like to gratefully acknowledge Dr Katharina Vezyroglou, Dr Marjorie Illingworth, Dr Pradnya Gadgil, Dr Teesta Soman, and Dr Shelly Weiss, previous contributors to this topic.

Disclosures

KV, MI, PG, TS, and SW declare that they have no competing interests.

Peer reviewers

Gregory L. Holmes, MD

Section Chief of Neurology

Dartmouth-Hitchcock Medical Center

Lebanon

NH

Disclosures

GLH declares that he has no competing interests.

Maria Roberta Cilio, MD, PhD

Attending Pediatric Neurologist

Division of Neurology

Bambino Gesu Children's Hospital

Rome

Italy

Disclosures

MRC declares that she has no competing interests.

Lionel Carmant, MD

Professor of Neurology

Department of Pediatrics

University of Montreal

Director of Epilepsy Clinic and Research Group

Saint Justine Hospital

Montreal

QC

Canada

Disclosures

LC declares that he has no competing interests.

Use of this content is subject to our disclaimer